<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.0?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Rev Soc Bras Med Trop</journal-id><journal-id journal-id-type="iso-abbrev">Rev Soc Bras Med Trop</journal-id><journal-id journal-id-type="publisher-id">rsbmt</journal-id><journal-title-group><journal-title>Revista da Sociedade Brasileira de Medicina Tropical</journal-title></journal-title-group><issn pub-type="ppub">0037-8682</issn><issn pub-type="epub">1678-9849</issn><publisher><publisher-name>Sociedade Brasileira de Medicina Tropical - SBMT</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7534965</article-id><article-id pub-id-type="doi">10.1590/0037-8682-0032-2020</article-id><article-id pub-id-type="other">00663</article-id><article-categories><subj-group subj-group-type="heading"><subject>Short Communication</subject></subj-group></article-categories><title-group><article-title>Antibacterial activity of <italic>Cinnamomum cassia</italic> L. essential oil in a carbapenem- and polymyxin-resistant <italic>Klebsiella aerogenes</italic> strain</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Vasconcelos</surname><given-names>Nathalie Gaebler</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref><xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Silva</surname><given-names>K&#x000e9;sia Esther</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Croda</surname><given-names>J&#x000fa;lio</given-names></name><xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref><xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0003-2367-0915</contrib-id><name><surname>Simionatto</surname><given-names>Simone</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref></contrib></contrib-group><aff id="aff1">
<label>1</label>Universidade Federal da Grande Dourados, Laborat&#x000f3;rio de Pesquisa em Ci&#x000ea;ncias da Sa&#x000fa;de, Dourados, MS, Brasil.</aff><aff id="aff2">
<label>2</label>Universidade Federal da Grande Dourados, Hospital Universit&#x000e1;rio de Dourados, Dourados, MS, Brasil.</aff><aff id="aff3">
<label>3</label>Funda&#x000e7;&#x000e3;o Oswaldo Cruz, Campo Grande, MS, Brasil.</aff><aff id="aff4">
<label>4</label>Universidade Federal do Mato Grosso do Sul, Campo Grande, MS, Brasil.</aff><author-notes><corresp id="c1"><bold>Corresponding author:</bold> Dra. Simone Simionatto. <bold>e-mail:</bold><email>simonesimionatto@ufgd.edu.br</email></corresp><fn fn-type="con" id="fn2"><p>
<bold>Authors&#x02019; Contribution:</bold> All authors contributed to the study conception and design. Material preparation, data collection and analysis were performed by <bold>NGV</bold> and <bold>KES</bold>. <bold>JC</bold> and <bold>SS</bold> supervised the research. The first draft of the manuscript was written by <bold>NGV</bold>, and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.</p></fn><fn fn-type="COI-statement" id="fn3"><p>
<bold>Conflict of Interest:</bold> The authors declare no conflicts of interest.</p></fn></author-notes><pub-date date-type="pub" publication-format="electronic"><day>05</day><month>10</month><year>2020</year></pub-date><pub-date date-type="collection" publication-format="electronic"><year>2020</year></pub-date><volume>53</volume><elocation-id>e20200032</elocation-id><history><date date-type="received"><day>31</day><month>1</month><year>2020</year></date><date date-type="accepted"><day>13</day><month>5</month><year>2020</year></date></history><permissions><license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License</license-p></license></permissions><abstract><title>Abstract</title><sec><title>INTRODUCTION:</title><p> Essential oils can serve as novel sources of antibiotics for multidrug-resistant bacteria.</p></sec><sec><title>METHODS:</title><p> The multidrug-resistance profile of a <italic>Klebsiella aerogenes</italic> strain was assessed by PCR and sequencing. The antibacterial activity of <italic>Cinnamomum cassia</italic> essential oil (CCeo) against <italic>K. aerogenes</italic> was assessed by broth microdilution and time-kill methods. </p></sec><sec><title>RESULTS:</title><p>
<italic>K. aerogenes</italic> showed high antibiotic resistance. The genes <italic>bla</italic>
<sub>KPC-2</sub>, <italic>ampC</italic>, <italic>bla</italic>
<sub>CTX-M-15</sub>, <italic>bla</italic>
<sub>OXA-1</sub>, and <italic>bla</italic>
<sub>TEM</sub> were present. CCeo exhibited an inhibitory effect with a minimum inhibitory concentration of 17.57 &#x003bc;g/mL. </p></sec><sec><title>CONCLUSIONS:</title><p> The antibacterial activity of CCeo makes it a potential candidate for treating carbapenem- and polymyxin-resistant <italic>K. aerogenes</italic> strains.</p></sec></abstract><kwd-group><title>Keywords:</title><kwd>Drug resistance</kwd><kwd>Cinnamon oil</kwd><kwd>Carbapenem-resistant Enterobacterales</kwd><kwd>Gram-negative bacteria</kwd><kwd>Klebsiella aerogenes</kwd><kwd>Polymyxin resistance</kwd></kwd-group><counts><fig-count count="2"/><table-count count="1"/><equation-count count="0"/><ref-count count="15"/></counts></article-meta></front><body><p>The emergence of multidrug-resistant bacteria is an important public health issue. <italic>Klebsiella aerogenes</italic>, previously known as <italic>Enterobacter aerogenes</italic>, has become an important opportunistic pathogen that often causes hospital-acquired infections such as pneumonia, urinary tract infections, bacteremia, and surgical site infections<xref rid="B1" ref-type="bibr">
<sup>1</sup>
</xref>. Worldwide, the number of infections caused by <italic>K. aerogenes</italic> strains with acquired resistance to most classes of commercially available antimicrobial agents, including carbapenems and polymyxins, is rising<xref rid="B2" ref-type="bibr">
<sup>2</sup>
</xref>. Carbapenems are often used to treat serious infections caused by <italic>K. aerogenes</italic>, especially those that produce AmpC cephalosporinases or extended-spectrum &#x003b2;-lactamases (ESBL)<xref rid="B1" ref-type="bibr">
<sup>1</sup>
</xref>, but carbapenem resistance can also arise. This scenario has led us to reconsider polymyxins as valuable therapeutic options. However, in addition to carbapenem resistance, various genera have demonstrated the ability to acquire polymyxin resistance<xref rid="B3" ref-type="bibr">
<sup>3</sup>
</xref>.</p><p>Carbapenemase-producing pathogens that are also resistant to polymyxins are a matter of concern, as these characteristics drastically reduce therapeutic options<xref rid="B4" ref-type="bibr">
<sup>4</sup>
</xref>. Carbapenem- and polymyxin-resistant Enterobacterales are considered critical by the World Health Organization, which has thus listed research into and development of new antibiotics as a high priority.</p><p>Polymyxin-resistant <italic>K. aerogenes</italic> strains have been identified and are being increasingly reported<xref rid="B5" ref-type="bibr">
<sup>5</sup>
</xref>. This highlights the urgency to find novel treatment options for carbapenem- and polymyxin-resistant bacterial infections. Molecular analysis of such strains may help improve our understanding of the antimicrobial resistance mechanisms and allow for the development of new and effective antibiotics.</p><p>With an increasing number of antibiotics rendered ineffective, the study of medicinal plants as potential sources of novel antibiotics, especially for the treatment of multidrug-resistant infections, has increased<xref rid="B5" ref-type="bibr">
<sup>5</sup>
</xref>. Plant-derived essential oils contain potent natural agents, known as secondary metabolites, that have been used for hundreds of years against pathogens<xref rid="B6" ref-type="bibr">
<sup>6</sup>
</xref>. An important characteristic in essential oils is their hydrophobicity, which allows them to interact with the lipids in the bacterial cell membrane and disturb the bacterial structure, thereby making it more permeable and leading to the leakage of ions and various molecules from the bacterial cells. Although the extravasation of cellular components can be tolerated without loss of viability, further loss of cellular content or the loss of critical molecules and ions can lead to cell death<xref rid="B4" ref-type="bibr">
<sup>4</sup>
</xref>. <italic>Cinnamomum cassia</italic> L. (Lauraceae) essential oil (CCeo), popularly known as cinnamon, contains a wide variety of secondary metabolites and has been shown to exhibit antimicrobial effects<xref rid="B7" ref-type="bibr">
<sup>7</sup>
</xref>. In this study, the antimicrobial activity of CCeo in the inhibition of a carbapenem- and polymyxin-resistant <italic>K. aerogenes</italic> strain was evaluated.</p><p>CCeo is a yellow to yellow brown clear oily liquid, extracted from leaves, bark, and branches by steam distillation, with a density of 1.053 g/cm<sup>3</sup>. CCeo originated in China, and this compound was acquired commercially from Ferquima (Vargem Grande Paulista, SP, Brazil) (CAS number: 84961-46-6). According to the chromatographic technical report provided by the supplier, cinnamaldehyde was the most prevalent compound (87.6%), followed by &#x003b1;-humulene (3.1%), &#x003b3;-elemene (2.5%), borneol (1.5%), cinnamic acid (0.7%), benzaldehyde (0.5%), and eugenol (0.4%), and other minor components (3.7%) (<xref ref-type="fig" rid="f1">Figure 1</xref>).</p><p>
<fig id="f1" orientation="portrait" position="float"><label>FIGURE 1:</label><caption><title>The chromatographic profile obtained with high-resolution gas chromatography for <italic>Cinnamomum cassia</italic> oil using an AGILENT 7820A Gas Chromatograph. Column: HP-5 30 m &#x000d7; 0.32 mm &#x000d7; 0.25 &#x003bc;m (AGILENT). Temp.: Column: 70&#x000b0;C (0 min), 3&#x000b0;C/min at 240&#x000b0;C. Injector: 240&#x000b0;C Split: 1/50. FID detector: 250&#x000b0;C. Vol. injection time: 1 &#x000b5;L (conc 1.0% in chloroform). Vany Ferraz, Chemistry Department, Universidade Federal de Minas Gerais. Requested by Ferquima (Vargem Grande Paulista, SP, Brazil).</title></caption><graphic xlink:href="1678-9849-rsbmt-53-e20200032-gf1"/></fig>
</p><p>A clinical isolate of a carbapenem- and polymyxin-resistant <italic>K. aerogenes</italic> was identified in September 2015 in a microbiological vigilance culture (nasal swab) at a tertiary Brazilian hospital. The isolate was identified using BD Phoenix 100 (Becton Dickinson, Franklin Lakes, NJ) and the antimicrobial susceptibility was determined by broth microdilution and by using BD Phoenix 100. Preliminary screening for the presence of carbapenemase was performed using the modified Hodge test<xref rid="B8" ref-type="bibr">
<sup>8</sup>
</xref>. The study was conducted with the approval of the Research Ethics Committee of the Universidade Federal da Grande Dourados (Process no. 877.292/2014).</p><p>Polymerase chain reaction (PCR) and sequencing were performed to determine the presence of the carbapenems-resistance genes <italic>bla</italic>
<sub>CTX-M-1-like</sub>, <italic>bla</italic>
<sub>CTX-M-2-like</sub>, <italic>bla</italic>
<sub>CTX-M-8-like</sub>, <italic>bla</italic>
<sub>CTX-M-14-like</sub>, <italic>bla</italic>
<sub>GES-like</sub>, <italic>bla</italic>
<sub>GIM-like</sub>, <italic>bla</italic>
<sub>IMP-10</sub>, <italic>bla</italic>
<sub>IMP-like</sub>, <italic>bla</italic>
<sub>KPC-2</sub>
<italic>, bla</italic>
<sub>NDM-like</sub>, <italic>bla</italic>
<sub>OXA-23</sub>, <italic>bla</italic>
<sub>OXA-48-like</sub>, <italic>bla</italic>
<sub>SHV-like</sub>, <italic>bla</italic>
<sub>SIM-like</sub>, <italic>bla</italic>
<sub>SME-like</sub>, <italic>bla</italic>
<sub>SPM-like</sub>, <italic>bla</italic>
<sub>TEM-like</sub>, and <italic>bla</italic>
<sub>VIM-like</sub>
<xref rid="B2" ref-type="bibr">
<sup>2</sup>
</xref>, and the polymyxin B-resistant gene <italic>mcr-1</italic>
<xref rid="B5" ref-type="bibr">
<sup>5</sup>
</xref>.</p><p>Genomic DNA was extracted from a fresh culture. The concentration and purity of the DNA were determined with a Qubit 2.0 fluorometer using the dsDNA BR Assay Kit (Life Technologies, Carlsbad, CA). A sequencing library was prepared using the Nextera library kit (Illumina, San Diego, CA). The DNA sample was sequenced using the Illumina MiSeq Platform (Illumina), as described by Dung et al.<xref rid="B9" ref-type="bibr">
<sup>9</sup>
</xref> Readings were mapped to a reference sequence, and species identification was confirmed using the taxonomic classification system of Kraken<xref rid="B10" ref-type="bibr">
<sup>10</sup>
</xref>. The reading set was assembled using SPAdes version 3.6.1 and annotated using the software tool Prokka<xref rid="B11" ref-type="bibr">
<sup>11</sup>
</xref>. The reading set was also screened for known alleles using a reading mapping approach with SRST2, the Short Read Sequence Typing for Bacterial Pathogens. For the acquired resistance genes, the Antibiotic Resistance Gene-ANNOTation (ARG-ANNOT) database was used<xref rid="B12" ref-type="bibr">
<sup>12</sup>
</xref>.</p><p>The minimum inhibitory concentration (MIC) of CCeo was determined by broth microdilution and by using a resazurin colorimetric assay<xref rid="B13" ref-type="bibr">
<sup>13</sup>
</xref>. The tested concentration range of CCeo was 72,000 &#x003bc;g/mL-2.197 &#x003bc;g/mL. The time-kill method was performed using the broth macrodilution technique<xref rid="B14" ref-type="bibr">
<sup>14</sup>
</xref>. The concentration of CCeo and polymyxin B tested represented the MIC value. Time-kill studies were performed with approximately 1.5 &#x000d7; 10<sup>6</sup> CFU/mL. A positive control of tigecycline was used at twice the MIC value, since the studied strain had an intermediate sensitivity to this antibiotic and there was no sensitivity to other pharmacological classes. A negative control of brain heart infusion broth was used for the bacterial strain, and saline was used as sterility control.</p><p>The <italic>K. aerogenes</italic> strain has an ESBL-, carbapenem- and polymyxin-resistant profile (<xref rid="t1" ref-type="table">Table 1</xref>). The genomic data assembled using ResFinder identified 17 resistance genes. The metallo-&#x003b2;-lactamase resistance genes identified were <italic>ampC</italic>, <italic>bla</italic>
<sub>CTX-M-15</sub>, <italic>bla</italic>
<sub>KPC-2</sub>, <italic>bla</italic>
<sub>OXA-1</sub>, and <italic>bla</italic>
<sub>TEM</sub>. Other resistance genes observed in this strain, including <italic>aac3, aac6, aphA6, catB4, dfrA8, dfrA14, qnrB1, strA, strB, sul2, tetA</italic>, and <italic>tetR</italic>, conferred resistance to aminoglycosides, chloramphenicol, trimethoprim, fluoroquinolones, streptomycin, sulfamethoxazole, and tetracycline. The genes <italic>bla</italic>
<sub>CTX-M-1-like</sub>, <italic>bla</italic>
<sub>CTX-M-2-like</sub>, <italic>bla</italic>
<sub>CTX-M-8-like</sub>, <italic>bla</italic>
<sub>CTX-M-14-like</sub>, <italic>bla</italic>
<sub>GES-like</sub>, <italic>bla</italic>
<sub>GIM-like</sub>, <italic>bla</italic>
<sub>IMP-10</sub>, <italic>bla</italic>
<sub>IMP-like</sub>, <italic>bla</italic>
<sub>NDM-like</sub>, <italic>bla</italic>
<sub>OXA-23</sub>, <italic>bla</italic>
<sub>OXA-24,</sub>
<italic>bla</italic>
<sub>OXA-48,</sub>
<italic>bla</italic>
<sub>OXA-48-like</sub>, <italic>bla</italic>
<sub>OXA-51,</sub>
<italic>bla</italic>
<sub>OXA-58,</sub>
<italic>bla</italic>
<sub>SHV-like</sub>, <italic>bla</italic>
<sub>SIM-like</sub>, <italic>bla</italic>
<sub>SME-like</sub>, <italic>bla</italic>
<sub>SPM-like</sub>, <italic>bla</italic>
<sub>TEM-like</sub>, <italic>bla</italic>
<sub>VIM-like</sub>, and <italic>mcr-1</italic> were not detected.</p><p>
<table-wrap id="t1" orientation="portrait" position="float"><label>TABLE 1:</label><caption><title>Antimicrobial susceptibility patterns (MICs in &#x000b5;g/mL).</title></caption><table frame="hsides" rules="groups"><colgroup span="1"><col span="1"/><col span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Antibiotics</th><th align="center" rowspan="1" colspan="1">MIC (interpretation)</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Amikacin</td><td align="center" rowspan="1" colspan="1">32 (I)</td></tr><tr><td align="left" rowspan="1" colspan="1">Aztreonam</td><td align="center" rowspan="1" colspan="1">&#x0003e; 16 (R)</td></tr><tr><td align="left" rowspan="1" colspan="1">Ceftazidime</td><td align="center" rowspan="1" colspan="1">&#x0003e; 16 (R)</td></tr><tr><td align="left" rowspan="1" colspan="1">Cefepime</td><td align="center" rowspan="1" colspan="1">&#x0003e; 16 (R)</td></tr><tr><td align="left" rowspan="1" colspan="1">Ceftriaxone</td><td align="center" rowspan="1" colspan="1">&#x0003e; 32 (R)</td></tr><tr><td align="left" rowspan="1" colspan="1">Ciprofloxacin</td><td align="center" rowspan="1" colspan="1">&#x0003e; 2 (R)</td></tr><tr><td align="left" rowspan="1" colspan="1">Ertapenem</td><td align="center" rowspan="1" colspan="1">&#x0003e; 4 (R)</td></tr><tr><td align="left" rowspan="1" colspan="1">Gentamicin</td><td align="center" rowspan="1" colspan="1">&#x02264; 2 (R)</td></tr><tr><td align="left" rowspan="1" colspan="1">Imipenem</td><td align="center" rowspan="1" colspan="1">8 (R)</td></tr><tr><td align="left" rowspan="1" colspan="1">Meropenem</td><td align="center" rowspan="1" colspan="1">8 (R)</td></tr><tr><td align="left" rowspan="1" colspan="1">Piperacillin/Tazobactam</td><td align="center" rowspan="1" colspan="1">&#x0003e; 64 (R)</td></tr><tr><td align="left" rowspan="1" colspan="1">Polymyxin B</td><td align="center" rowspan="1" colspan="1">&#x0003e; 4 (R)</td></tr><tr><td align="left" rowspan="1" colspan="1">Tigecycline</td><td align="center" rowspan="1" colspan="1">2 (I)</td></tr><tr><td align="left" rowspan="1" colspan="1">Sulfamethoxazole/Trimethoprim</td><td align="center" rowspan="1" colspan="1">&#x0003e; 4 (R)</td></tr></tbody></table><table-wrap-foot><fn id="TFN1"><p>
<bold>(I):</bold> intermediate; <bold>(R):</bold> resistance; <bold>MIC:</bold> minimum inhibitory concentration.</p></fn></table-wrap-foot></table-wrap>
</p><p>Antimicrobial resistance to carbapenems and polymyxin B was confirmed. Molecular analysis was used to identify the <italic>bla</italic>
<sub>KPC-2</sub> gene, elucidating the mechanism of carbapenem resistance. Sequencing also allowed us to identify other metallo-&#x003b2;-lactamase genes, such as <italic>ampC</italic>, <italic>bla</italic>
<sub>CTX-M-15</sub>, <italic>bla</italic>
<sub>OXA-1</sub>, and <italic>bla</italic>
<sub>TEM</sub>, which provide <italic>K. aerogenes</italic> with a wide range of resistance mechanisms, possibly capable of transferring related genes, leading to an increase resistance to antibiotics, thus making it very difficult to treat infections caused by this bacterial strain. Resistance to polymyxin B due to the presence of <italic>mcr-1</italic> gene was not considered. However, sequencing results showed alterations in the <italic>phoP</italic> gene, indicating a potential mechanism of mutational colistin resistance in this strain.</p><p>CCeo exhibited an inhibitory effect against the carbapenem- and polymyxin-resistant <italic>K. aerogenes</italic> strain even at a low concentration (0.0019% v/v) and had a MIC value of 17.57 &#x003bc;g/mL. The survival curve of the strain showed a decrease in viable cell counts over time (<xref ref-type="fig" rid="f2">Figure 2</xref>). CCeo treatment decreased cell counts by approximately 5 log<sub>10</sub> CFU/mL. The results showed total inhibition of the carbapenem- and polymyxin-resistant <italic>K. aerogenes</italic>, with cell counts reduced to zero after 24 h of CCeo treatment. Furthermore, polymyxin B showed no activity for up to 24 h. Tigecycline was used at twice the MIC value as a positive control and was found to inhibit the strain successfully within 24 h.</p><p>
<fig id="f2" orientation="portrait" position="float"><label>FIGURE 2:</label><caption><title>Time-kill curves with CCeo against a carbapenem and polymyxin-resistant <italic>K. aerogenes</italic> strain. <bold>CCeo:</bold>
<italic>Cinnamomum cassia</italic> L. essential oil; <bold>MIC:</bold> minimum inhibitory concentration; <bold>PMB:</bold> polymyxin B; <bold>TGC:</bold> tigecycline; <bold>C+:</bold> positive control (tigecycline at twice the MIC value); <bold>C-:</bold> negative control (<italic>K. aerogenes</italic> and brain heart infusion broth).</title></caption><graphic xlink:href="1678-9849-rsbmt-53-e20200032-gf2"/></fig>
</p><p>CCeo demonstrated promising antibacterial properties against the carbapenem- and polymyxin-resistant <italic>K. aerogenes</italic> strain, a bacterial strain resistant to almost all classes of clinical antibiotics, with a low MIC and a consistent action. To the best of our knowledge, this is the first report on the antibacterial activity of CCeo against multidrug-resistant <italic>K. aerogenes</italic>. In addition, to determine MIC values, an improved time-kill method was used, which allowed us to verify the speed of the inhibition activity of CCeo on the studied bacteria, to enhance our understanding of the underlying mechanism of action of CCeo.</p><p>Our results suggest that the CCeo antibacterial action mechanism is complex. Several pathways may be involved in the inhibitory effects of this oil against bacterial cells, making it difficult to elucidate them all. Multiple experiments are necessary in order to evaluate all possible mechanisms and provide an insight into the molecular actions of CCeo. The antimicrobial activity of essential oils may involve single or multiple targets. Therefore, the mechanisms of action cannot be attributed to a unique site, but rather to a cascade of reactions involving the entire bacterial cell<xref rid="B6" ref-type="bibr">
<sup>6</sup>
</xref>.</p><p>Regarding CCeo toxicity, the major components of <italic>C. cassia</italic> are considered to be non-toxic and safe, with no acute or chronic toxicity, no mutagenicity or genotoxicity, and no carcinogenicity detected in mammalian studies<xref rid="B15" ref-type="bibr">
<sup>15</sup>
</xref>, making CCeo even more suitable for use as raw material in drug development.</p><p>Effective antimicrobial activity was observed at low concentrations, indicating that CCeo is a favorable candidate for <italic>in vivo</italic> studies in animal models to demonstrate its clinical applicability for the future development of antimicrobial treatments. Our findings fall in line with the critical need for novel sources of antibiotics to address an increasing incidence of drug-resistant pathogens, especially multidrug-resistant bacteria. However, this study had some limitations. Studies on other multidrug-resistant bacteria and <italic>in vivo</italic> studies are necessary to better understand the mechanisms of action of CCeo.</p><p>Our data reveal that the CCeo had an antibacterial effect, making it an interesting candidate for the development of therapeutic options against carbapenem- and polymyxin-resistant <italic>K. aerogenes</italic> strains. Further studies on CCeo activity in animals infected with multidrug-resistant bacteria are essential in order to further improve our understanding of its actions and establish its efficacy.</p></body><back><ack><title>ACKNOWLEDGMENTS</title><p>The authors are grateful for the financial support and infrastructure provided by the Universidade Federal da Grande Dourados (UFGD), which made this study possible, and Hospital Universit&#x000e1;rio da Universidade Federal da Grande Dourados (HU-UFGD) for providing the microbial strain used in the study. K.E.S. received a scholarship from Coordena&#x000e7;&#x000e3;o de Aperfei&#x000e7;oamento de Pessoal de N&#x000ed;vel Superior (CAPES). This study was conducted with the approval of the Research Ethics Committee of the Universidade Federal da Grande Dourados (no. 877292/2014).</p></ack><fn-group><fn fn-type="financial-disclosure" id="fn1"><p>
<bold>Financial Support:</bold> This work was partially supported by the National Council for Scientific and Technological Development (CNPq), Funda&#x000e7;&#x000e3;o de Apoio ao Desenvolvimento do Ensino, Ci&#x000ea;ncia e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT grants 092/2015 and 041/2017), Coordena&#x000e7;&#x000e3;o de Aperfei&#x000e7;oamento de Pessoal de N&#x000ed;vel Superior (CAPES, grant 001), and Universidade Federal da Grande Dourados (UFGD). K.E.S. received a scholarship from CAPES.</p></fn></fn-group><ref-list><title>REFERENCES</title><ref id="B1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>L</given-names></name><name><surname>Yu</surname><given-names>J</given-names></name><name><surname>Cao</surname><given-names>X</given-names></name><name><surname>Zhan</surname><given-names>Q</given-names></name><name><surname>Guo</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Coexistence of bla NDM-1 and rmtC on a Transferrable Plasmid of a Novel ST192 Klebsiella aerogenes Clinical Isolate</article-title><source>Infect Drug Resist</source><year>2019</year><volume>12</volume><fpage>3883</fpage><lpage>3891</lpage><pub-id pub-id-type="doi">10.2147/IDR.S228130</pub-id><pub-id pub-id-type="pmid">31853191</pub-id></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Silva</surname><given-names>KE</given-names></name><name><surname>Cay&#x000f4;</surname><given-names>R</given-names></name><name><surname>Carvalhaes</surname><given-names>CG</given-names></name><name><surname>Sachi</surname><given-names>FPC</given-names></name><name><surname>Rodrigues-Costa</surname><given-names>F</given-names></name><name><surname>Ramos da Silva</surname><given-names>AC</given-names></name><etal/></person-group><article-title>Coproduction of KPC-2 and IMP-10 in Carbapenem-Resistant Serratia marcescens Isolates from an Outbreak in a Brazilian Teaching Hospital</article-title><source>J Clin Microbiol</source><year>2015</year><volume>53</volume><issue>7</issue><fpage>2324</fpage><lpage>2328</lpage><pub-id pub-id-type="doi">10.1128/JCM.00727-15</pub-id><pub-id pub-id-type="pmid">25878341</pub-id></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>da Silva</surname><given-names>KE</given-names></name><name><surname>Baker</surname><given-names>S</given-names></name><name><surname>Croda</surname><given-names>J</given-names></name><name><surname>Nguyen</surname><given-names>TNT</given-names></name><name><surname>Boinett</surname><given-names>CJ</given-names></name><name><surname>Barbosa</surname><given-names>LS</given-names></name><etal/></person-group><article-title>Risk factors for polymyxin-resistant carbapenemase-producing Enterobacteriaceae in critically patients: An epidemiological and clinical study</article-title><source>Int J Antimicrob Agents</source><year>2020</year><volume>55</volume><issue>3</issue><fpage>105882</fpage><lpage>105882</lpage><pub-id pub-id-type="doi">10.1016/j.ijantimicag.2020.105882</pub-id><pub-id pub-id-type="pmid">31923570</pub-id></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nazzaro</surname><given-names>F</given-names></name><name><surname>Fratianni</surname><given-names>F</given-names></name><name><surname>De Martino</surname><given-names>L</given-names></name><name><surname>Coppola</surname><given-names>R</given-names></name><name><surname>De Feo</surname><given-names>V</given-names></name></person-group><article-title>Effect of Essential Oils on Pathogenic Bacteria</article-title><source>Pharmaceuticals</source><year>2013</year><volume>6</volume><issue>12</issue><fpage>1451</fpage><lpage>1474</lpage><pub-id pub-id-type="doi">10.3390/ph6121451</pub-id><pub-id pub-id-type="pmid">24287491</pub-id></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>YY</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Walsh</surname><given-names>TR</given-names></name><name><surname>Yi</surname><given-names>LX</given-names></name><name><surname>Zhang</surname><given-names>R</given-names></name><name><surname>Spencer</surname><given-names>J</given-names></name><etal/></person-group><article-title>Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study</article-title><source>Lancet Infect Dis</source><year>2016</year><volume>16</volume><issue>2</issue><fpage>161</fpage><lpage>168</lpage><pub-id pub-id-type="doi">10.1016/S1473-3099(15)00424-7</pub-id><pub-id pub-id-type="pmid">26603172</pub-id></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vasconcelos</surname><given-names>NG</given-names></name><name><surname>Croda</surname><given-names>J</given-names></name><name><surname>Simionatto</surname><given-names>S</given-names></name></person-group><article-title>Antibacterial mechanisms of cinnamon and its constituents: A review</article-title><source>Microb Pathog</source><year>2018</year><volume>120</volume><fpage>198</fpage><lpage>203</lpage><pub-id pub-id-type="doi">10.1016/j.micpath.2018.04.036</pub-id><pub-id pub-id-type="pmid">29702210</pub-id></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yap</surname><given-names>PS</given-names></name><name><surname>Krishnan</surname><given-names>T</given-names></name><name><surname>Chan</surname><given-names>KG</given-names></name><name><surname>Lim</surname><given-names>SH</given-names></name></person-group><article-title>Antibacterial Mode of Action of Cinnamomum verum Bark Essential Oil, Alone and in Combination with Piperacillin, Against a Multi-Drug-Resistant Escherichia coli Strain</article-title><source>J Microbiol Biotechnol</source><year>2015</year><volume>25</volume><issue>8</issue><fpage>1299</fpage><lpage>1306</lpage><pub-id pub-id-type="doi">10.4014/jmb.1407.07054</pub-id><pub-id pub-id-type="pmid">25381741</pub-id></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="report"><person-group person-group-type="author"><collab>Clinical Laboratory Standards Institute</collab></person-group><source>Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Five Informational Supplement</source><pub-id pub-id-type="other">CLSI Document M100-S25</pub-id><year>2015</year></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dung</surname><given-names>TTN</given-names></name><name><surname>Duy</surname><given-names>PT</given-names></name><name><surname>Sessions</surname><given-names>OM</given-names></name><name><surname>Sangumathi</surname><given-names>UK</given-names></name><name><surname>Phat</surname><given-names>VV</given-names></name><name><surname>Tam</surname><given-names>PTT</given-names></name><etal/></person-group><article-title>A universal genome sequencing method for rotavirus A from human fecal samples which identifies segment reassortment and multi-genotype mixed infection</article-title><source>BMC Genomics</source><year>2017</year><volume>18</volume><issue>1</issue><fpage>324</fpage><lpage>324</lpage><pub-id pub-id-type="doi">10.1186/s12864-017-3714-6</pub-id><pub-id pub-id-type="pmid">28438140</pub-id></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wood</surname><given-names>DE</given-names></name><name><surname>Salzberg</surname><given-names>SL</given-names></name></person-group><article-title>Kraken: ultrafast metagenomic sequence classification using exact alignments</article-title><source>Genome Biol</source><year>2014</year><volume>15</volume><issue>3</issue><fpage>R46</fpage><lpage>R46</lpage><pub-id pub-id-type="doi">10.1186/gb-2014-15-3-r46</pub-id><pub-id pub-id-type="pmid">24580807</pub-id></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seemann</surname><given-names>T</given-names></name></person-group><article-title>Prokka: rapid prokaryotic genome annotation</article-title><source>Bioinformatics</source><year>2014</year><volume>30</volume><issue>14</issue><fpage>2068</fpage><lpage>2069</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btu153</pub-id><pub-id pub-id-type="pmid">24642063</pub-id></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gupta</surname><given-names>SK</given-names></name><name><surname>Padmanabhan</surname><given-names>BR</given-names></name><name><surname>Diene</surname><given-names>SM</given-names></name><name><surname>Lopez-Rojas</surname><given-names>R</given-names></name><name><surname>Kempf</surname><given-names>M</given-names></name><name><surname>Landraud</surname><given-names>L</given-names></name><etal/></person-group><article-title>ARG-ANNOT, a new bioinformatic tool to discover antibiotic resistance genes in bacterial genomes</article-title><source>Antimicrob Agents Chemother</source><year>2014</year><volume>58</volume><issue>1</issue><fpage>212</fpage><lpage>220</lpage><pub-id pub-id-type="doi">10.1128/AAC.01310-13</pub-id><pub-id pub-id-type="pmid">24145532</pub-id></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cavalcanti</surname><given-names>YW</given-names></name><name><surname>Almeida</surname><given-names>LFD</given-names></name><name><surname>Padilha</surname><given-names>WWN</given-names></name></person-group><article-title>Antifungal Activity of Three Essential Oils on Candida Strains</article-title><source>Rev Odontol Bras Central</source><year>2011</year><volume>20</volume><issue>52</issue><fpage>68</fpage><lpage>73</lpage><pub-id pub-id-type="doi">10.1155/2017/7158756</pub-id></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vasconcelos</surname><given-names>NG</given-names></name><name><surname>Croda</surname><given-names>J</given-names></name><name><surname>Silva</surname><given-names>KE</given-names></name><name><surname>Motta</surname><given-names>MLL</given-names></name><name><surname>Maciel</surname><given-names>WG</given-names></name><name><surname>Limiere</surname><given-names>LC</given-names></name><etal/></person-group><article-title>Origanum vulgare L. essential oil inhibits the growth of carbapenem-resistant gram-negative bacteria</article-title><source>Rev Soc Bras Med Trop</source><year>2019</year><volume>52</volume><elocation-id>e20180502</elocation-id><pub-id pub-id-type="doi">10.1590/0037-8682-0502-2018</pub-id><pub-id pub-id-type="pmid">31271619</pub-id></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bickers</surname><given-names>D</given-names></name><name><surname>Calow</surname><given-names>P</given-names></name><name><surname>Greim</surname><given-names>H</given-names></name><name><surname>Hanifin</surname><given-names>JM</given-names></name><name><surname>Rogers</surname><given-names>AE</given-names></name><name><surname>Saurat</surname><given-names>JH</given-names></name><etal/></person-group><article-title>A toxologic and dermatologic assessment of cinnamyl alcohol, cinnamaldehyde and cinnamic acid when used as fragrance ingredients. The RIFM expert panel</article-title><source>Food Chem Toxicol</source><year>2005</year><volume>43</volume><fpage>799</fpage><lpage>836</lpage><pub-id pub-id-type="doi">10.1016/j.fct.2004.09.013</pub-id><pub-id pub-id-type="pmid">15811570</pub-id></element-citation></ref></ref-list></back></article>